Accessibility Statement Skip Navigation
  • Back to Global Sites
  • +972-77-2005042
  • Blog
  • Journalists
  • GDPR
  • Send a Release
PR Newswire: news distribution, targeting and monitoring
  • News
  • Products
  • Contact
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • Telephone

    • +972-77-2005042 from 8 AM - 11 PM IL

    • Contact
    • Contact

      +972-77-2005042
      from 8 AM - 11 PM IL

Close menu
  • News
  • Products
  • Contact
    • Request More Information
    • Journalists
    • GDPR

    PhaseV Bringing Integrated AI for Faster Clinical Trials to the Global Stage

    PhaseV logo

    News provided by

    PhaseV

    26 Mar, 2026, 14:30 IST

    Share this article

    Share this article


    Moving Beyond Basic AI Adoption, PhaseV Will Demonstrate How Causal AI/ML Achieves Significant Improvements in Trial Design, Execution and Patient Outcomes

    BOSTON, March 26, 2026 /PRNewswire/ -- PhaseV, a leader in AI/ML for clinical development, today announced its spring and summer 2026 conference schedule. PhaseV's leadership will demonstrate how the integration of Bayesian statistics and Causal AI/ML provides the technical foundation for more flexible, robust, and accelerated clinical trials.

    "Widespread AI adoption in pharma is here, and we are focused on helping sponsors do it right," said Raviv Pryluk, PhD, CEO and Co-founder of PhaseV. "We are proud to lead the charge in applying causal ML to optimize trial design and workflows and de-risk development. Our mission is clear: help biopharma teams successfully integrate modern, data-driven tools that accelerate programs and bring promising therapies to patients sooner."

    Featured speaking engagements and exhibits include:

    • Duke Industry Statistics Symposium - DISS (Cary, NC) | April 8-10
      Presentation: AI-Assisted Bayesian Causal ML Methods and Software for Modern Biopharmaceutical Development.

    • The Chief Medical Officer (CMO) Summit 360° (Boston, MA) | April 13-14
      Session: From Insight to Action: How CMOs Can Use Causal AI to De-Risk Clinical Development (Led by CEO Raviv Pryluk, PhD)

    • AWS Life Sciences Symposium 2026 (New York, NY) | April 14
      PhaseV will join industry leaders to discuss the intersection of cloud computing and advanced AI in clinical trials.

    • Clinical Outsourcing Group (COG) New England (Boston, MA) | April 28-29

    Keynote Presentation & Booth #39

    The team will later be presenting at:

    • Fierce Biotech Week (Boston, MA) | May 12-14 - Presentation & Exhibit

    • ISPOR 2026 (Philadelphia, PA) | May 17-20 - Two Poster Presentations & Exhibit

    • ScopeX (Boston, MA) | May 18-19 - Presentation & Exhibit

    • BIO IT World (Boston, MA) | May 18-21 - AI in Oncology Presentation & Booth #711

    • DIA 2026 (Philadelphia, PA) | June 14-18 - Exhibit Booth #1204

    • PSI 2026 (Belfast, Northern Ireland) | June 15-17 - Poster Presentation

    • Longwood Healthcare Leaders MIT CEO (Cambridge, MA) | June 16
      CEO Raviv Pryluk, PhD, will moderate a panel: Drug Approvals: Insights, Outlook, and Commitment to Patients

    PhaseV representatives will also be available for briefings, demos and networking at the following events:

    • BBSW AI Solution Summit (Foster, CA) | May 15
    • BioMed Israel (Tel Aviv, Israel) | May 12-14
    • BIO International (San Diego, CA) | June 22-25
    • EULAR 2026 (London, UK) | June 3-6

    To schedule a meeting or a demo with the PhaseV team, please contact [email protected].

    About PhaseV 

    Boston-based PhaseV is leading the next era of clinical development through its integrated, multi-modal AI/ML platform that optimizes every phase of the clinical trial lifecycle. The company's core solutions – including the ClinOps, Trial, Portfolio, and Response Optimizers – enable biopharma sponsors and CROs to select the best assets, indications, and patient populations and then rapidly design, plan, and execute optimized fixed, Bayesian, and adaptive trials. With intelligent, data-driven solutions, PhaseV has delivered significant ROI for over 45 leading pharma and biotech sponsors across multiple therapeutic areas, reducing trial costs by up to 50% and increasing the probability of success by over 30%.

    Learn more at www.PhaseVTrials.com and follow us on LinkedIn.

    Logo - https://mma.prnewswire.com/media/2267452/PhaseV_logo.jpg

    Media Contact:

    Ellie Hanson
    FINN Partners for PhaseV
    [email protected]

    SOURCE PhaseV

    Modal title

    Also from this source

    PhaseV Launches BonV, an Agentic AI Orchestrator Turning Clinical Questions into Defensible Decisions

    PhaseV Launches BonV, an Agentic AI Orchestrator Turning Clinical Questions into Defensible Decisions

    PhaseV, a clinical development technology company that applies AI and causal machine learning to help biopharma make faster, more informed decisions, ...

    PhaseV Validates GLP-1 Adverse Event Model on MarketScan and Veradigm Real-World Patient Data

    PhaseV Validates GLP-1 Adverse Event Model on MarketScan and Veradigm Real-World Patient Data

    PhaseV, a leader in machine learning for clinical development, today reported validation results for a causal model that predicts adverse events,...

    More Releases From This Source

    Contact PR Newswire

    • +972-77-2005042
      from 8 AM - 11 PM IL

    Global Sites

    • APAC
    • APAC - Traditional Chinese
    • Asia
    • Brazil
    • Canada
    • Czech
    • Denmark
    • Finland
    • France
    • Germany

     

    • India
    • Indonesia
    • Israel
    • Italy
    • Mexico
    • Middle East
    • Middle East - Arabic
    • Netherlands
    • Norway
    • Poland

     

    • Portugal
    • Russia
    • Slovakia
    • Spain
    • Sweden
    • United Kingdom
    • United States

    Do not sell or share my personal information:

    • Submit via [email protected] 
    • Call Privacy toll-free: 877-297-8921
    Global Sites
    • Asia
    • Brazil
    • Canada
    • Csezh
    • Denmark
    • Finland
    • France
    • Germany
    • India
    • Israel
    • Italie
    • Mexico
    • Middle East
    • Netherlands
    • Norway
    • Poland
    • Portugal
    • Russia
    • Slovakia
    • Spain
    • Sweden
    • United Kingdom
    • United States
    +972-77-2005042
    from 8 AM - 11 PM IL
    • Terms of Use
    • Privacy Policy
    • Information Security Policy
    • Site Map
    • Cookie Settings
    Copyright © 2026 Cision US Inc.